Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674422 | SCV000799757 | likely pathogenic | Maple syrup urine disease | 2018-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000674422 | SCV001374116 | pathogenic | Maple syrup urine disease | 2022-10-06 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 253 of the BCKDHA protein (p.Ala253Thr). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on BCKDHA protein function. ClinVar contains an entry for this variant (Variation ID: 558191). This variant is also known as A209T. This missense change has been observed in individual(s) with maple syrup urine disease (PMID: 8161368, 16786533, 17922217). This variant is present in population databases (rs199599175, gnomAD 0.007%). |
Baylor Genetics | RCV000674422 | SCV004215897 | pathogenic | Maple syrup urine disease | 2023-07-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835912 | SCV002088156 | likely pathogenic | Maple syrup urine disease type 1A | 2020-03-31 | no assertion criteria provided | clinical testing |